Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).
Baumann LS, Blauvelt A, Draelos ZD, Kempers SE, Lupo MP, Schlessinger J, Smith SR, Wilson DC, Bradshaw M, Estes E, Shanler SD. Baumann LS, et al. Among authors: lupo mp. J Am Acad Dermatol. 2018 Nov;79(5):869-877. doi: 10.1016/j.jaad.2018.05.044. Epub 2018 Jun 1. J Am Acad Dermatol. 2018. PMID: 29864467 Free article. Clinical Trial.
Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.
Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS; JUVEDERM vs. ZYPLAST Nasolabial Fold Study Group. Baumann LS, et al. Among authors: lupo mp. Dermatol Surg. 2007 Dec;33 Suppl 2:S128-35. doi: 10.1111/j.1524-4725.2007.33352.x. Dermatol Surg. 2007. PMID: 18086050 Clinical Trial.
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, Liu Y, Rubio RG; SAKURA 1 and SAKURA 2 Investigator Group; SAKURA 1 and SAKURA 2 Investigator Group includes the following. Carruthers JD, et al. Plast Reconstr Surg. 2020 Jan;145(1):45-58. doi: 10.1097/PRS.0000000000006327. Plast Reconstr Surg. 2020. PMID: 31609882 Free PMC article. Clinical Trial.
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: lupo mp. Aesthet Surg J. 2021 Nov 12;41(12):1409-1422. doi: 10.1093/asj/sjaa383. Aesthet Surg J. 2021. PMID: 33944905 Free PMC article. Clinical Trial.
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: lupo mp. Aesthet Surg J. 2021 Nov 12;41(12):1494. doi: 10.1093/asj/sjab229. Aesthet Surg J. 2021. PMID: 34309676 Free PMC article. No abstract available.
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Kircik LH, Stein Gold L, Gold M, Weiss JS, Harper JC, Del Rosso JQ, Bunick CG, Bhatia N, Tanghetti EA, Eichenfield LF, Baldwin H, Draelos ZD, Callender VD, Han G, Gooderham MJ, Sadick N, Lupo MP, Lain ET, Werschler WP. Kircik LH, et al. Among authors: lupo mp. Dermatol Ther (Heidelb). 2024 May;14(5):1211-1227. doi: 10.1007/s13555-024-01155-7. Epub 2024 May 9. Dermatol Ther (Heidelb). 2024. PMID: 38724841 Free PMC article.
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.
Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Davis PG, Yalamanchili R, Campo A, Beddingfield FC 3rd. Moers-Carpi M, et al. Dermatol Surg. 2015 Jan;41(1):102-12. doi: 10.1097/DSS.0000000000000220. Dermatol Surg. 2015. PMID: 25485803 Clinical Trial.
Nutraceuticals: A Review.
Souyoul SA, Saussy KP, Lupo MP. Souyoul SA, et al. Among authors: lupo mp. Dermatol Ther (Heidelb). 2018 Mar;8(1):5-16. doi: 10.1007/s13555-018-0221-x. Epub 2018 Feb 6. Dermatol Ther (Heidelb). 2018. PMID: 29411317 Free PMC article. Review.
42 results